| Literature DB >> 28303738 |
Joshua D Bernstock1,2, Luca Peruzzotti-Jametti1, Daniel Ye2, Florian A Gessler1, Dragan Maric2, Nunzio Vicario1, Yang-Ja Lee2, Stefano Pluchino1, John M Hallenbeck2.
Abstract
Ischemic stroke continues to be a leading cause of morbidity and mortality throughout the world. To protect and/or repair the ischemic brain, a multitiered approach may be centered on neural stem cell (NSC) transplantation. Transplanted NSCs exert beneficial effects not only via structural replacement, but also via immunomodulatory and/or neurotrophic actions. Unfortunately, the clinical translation of such promising therapies remains elusive, in part due to their limited persistence/survivability within the hostile ischemic microenvironment. Herein, we discuss current approaches for the development of NSCs more amenable to survival within the ischemic brain as a tool for future cellular therapies in stroke.Entities:
Keywords: Ischemic stroke; cellular engineering; neural stem cells; post-translational modifications; preconditioning
Mesh:
Year: 2017 PMID: 28303738 PMCID: PMC5531358 DOI: 10.1177/0271678X17700432
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200